BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8175417)

  • 1. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo.
    Rodriguez R; Ritter MA; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):105-13. PubMed ID: 8175417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
    Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
    Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of locally advanced cancer of the head and neck with 5'-iododeoxyuridine and hyperfractionated radiation therapy: measurement of cell labeling and thymidine replacement.
    Epstein AH; Lebovics RS; Goffman T; Teague D; Fuetsch ES; Glatstein E; Okunieff P; Cook JA
    J Natl Cancer Inst; 1994 Dec; 86(23):1775-80. PubMed ID: 7966416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
    Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
    Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.
    McGinn CJ; Kunugi KA; Tutsch KD; Feierabend C; Alberti D; Lindstrom MJ; Wilding G; Arzoomanian RZ; Kinsella TJ
    Clin Cancer Res; 1996 Aug; 2(8):1299-305. PubMed ID: 9816300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure.
    Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1393-8. PubMed ID: 2370189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cells.
    Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1992; 22(3):499-503. PubMed ID: 1735687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of hydroxyurea and iododeoxyuridine on the radiosensitivity of human bladder cancer cells.
    Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
    Cancer Res; 1995 Jul; 55(13):2800-5. PubMed ID: 7796406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines.
    Uhl V; Phillips TL; Ross GY; Bodell WJ; Rasmussen J
    Int J Radiat Oncol Biol Phys; 1992; 22(3):489-94. PubMed ID: 1735685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.
    Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
    Radiat Res; 1990 Aug; 123(2):192-8. PubMed ID: 2389005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: as a radiosensitizer and as a marker for cell kinetic studies.
    Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Smith R; Rowland J; Cupp JE; Collins JM
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1247-50. PubMed ID: 2715075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
    Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ
    Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of 5-iodo-2'-deoxyuridine incorporation in murine melanoma for photon activation therapy.
    Laster BH; Popenoe EA; Wielopolski L; Commerford SL; Gahbauer R; Goodman J; Meek A; Fairchild RG
    Radiother Oncol; 1990 Oct; 19(2):169-78. PubMed ID: 2255770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs.
    Kinsella TJ; Dobson PP; Mitchell JB; Fornace AJ
    Int J Radiat Oncol Biol Phys; 1987 May; 13(5):733-9. PubMed ID: 3570896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
    Lawrence TS; Davis MA; Maybaum J; Mukhopadhyay SK; Stetson PL; Normolle DP; McKeever PE; Ensminger WD
    Cancer Res; 1992 Jul; 52(13):3698-704. PubMed ID: 1617642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells.
    Kunugi KA; Vazquez-Padua MA; Miller EM; Kinsella TJ
    Cancer Res; 1990 Aug; 50(16):4962-7. PubMed ID: 2199032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific staining of iododeoxyuridine and bromodeoxyuridine in tumors double labelled in vivo: a cell kinetic analysis.
    Pollack A; Terry NH; Wu CS; Wise BM; White RA; Meistrich ML
    Cytometry; 1995 May; 20(1):53-61. PubMed ID: 7541331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
    Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
    Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of exposure time, concentration and incorporation of IdUrd in V-79 cells with radiation response.
    Phillips TL; Bodell WJ; Uhl V; Ross GY; Rasmussen J; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1251-5. PubMed ID: 2715076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.